title: Hepatitis C virus reinfection after liver transplant: New chances and new challenges in the era of direct-acting antiviral agents.
abstract: The first interferon-free regimens have been approved for the treatment of patients with chronic hepatitis C virus (HCV). In the liver transplant (LT) setting, these regimens are expected to have an important effect, because graft loss due to HCV recurrence is a serious problem after LT. The response to the hitherto conventional treatment with pegylated interferon and ribavirin is poor. The significantly better response rates achieved with boceprevir-based and telaprevir-based triple therapy have led to better graft and patient survival rates, but severe drug interactions with immunosuppressants limit the feasibility of this therapy for LT patients. With the approval of sofosbuvir in January 2014, of simeprevir in May 2014, and of daclatasvir in August 2014, three antiviral agents are now available and promise to be applicable without relevant adverse effects or negative interactions with immunosuppressants. Thus, 2014 marks the beginning of a new era of treatment options for HCV recurrence after LT. Although safety and efficacy studies of several interferon-free regimens for patients with HCV recurrence after LT have achieved good preliminary results, reports of clinical experiences with LT patients are scarce. The lack of randomized studies, the small number of enrolled and carefully selected patients, and the heterogeneity of these studies make the results questionable. Real-life experiences are eagerly awaited so that clinicians can estimate the usefulness and the pitfalls of these new regimens. Additionally, the high costs of these agents may limit their accessibility for many patients. The aim of this review is to summarize the current experience with and the expectations of the new direct-acting antiviral agents for LT patients.
authors.affiliation: Kerstin Herzer, Guido Gerken, Department of Gastroenterology and Hepatology, University Hospital Essen, 45122 Essen, Germany.
authors.forename: Kerstin
authors.initials: K
authors.lastname: Herzer
authors.affiliation: Kerstin Herzer, Guido Gerken, Department of Gastroenterology and Hepatology, University Hospital Essen, 45122 Essen, Germany.
authors.forename: Guido
authors.initials: G
authors.lastname: Gerken
keywords: Daclatasvir; Hepatitis C virus; Interferon; Liver transplant; Simeprevir; Sofosbuvir
references.citation: Hepatology. 2006 Mar;43(3):492-9
references.pmid: 16496308
references.citation: Transplantation. 2002 Jan 15;73(1):56-63
references.pmid: 11792978
references.citation: Semin Liver Dis. 2014 Feb;34(1):58-71
references.pmid: 24782259
references.citation: Gastroenterology. 2012 May;142(6):1279-1287.e3
references.pmid: 22537434
references.citation: Curr Top Microbiol Immunol. 2013;369:49-86
references.pmid: 23463197
references.citation: Hepatology. 2012 Nov;56(5):1622-30
references.pmid: 22576324
references.citation: Am J Transplant. 2005 Jan;5(1):118-24
references.pmid: 15636619
references.citation: Aliment Pharmacol Ther. 2014 Jun;39(12):1363-75
references.pmid: 24754233
references.citation: Dig Dis. 2014;32(5):525-37
references.pmid: 25034285
references.citation: J Viral Hepat. 2008 Oct;15(10):699-709
references.pmid: 18673428
references.citation: J Hepatol. 2012 Feb;56(2):455-63
references.pmid: 21884670
references.citation: Semin Gastrointest Dis. 2000 Apr;11(2):96-114
references.pmid: 10803634
references.citation: J Viral Hepat. 2014 May;21(5):333-40
references.pmid: 24716636
references.citation: Transplantation. 2015 Apr;99(4):841-7
references.pmid: 25208324
references.citation: PLoS One. 2011;6(9):e24387
references.pmid: 21931704
references.citation: Dtsch Med Wochenschr. 2013 Sep;138(36):1759-64
references.pmid: 24002874
references.citation: J Hepatol. 2009 Apr;50(4):719-28
references.pmid: 19217183
references.citation: J Hepatol. 2010 Nov;53(5):962-70
references.pmid: 20800307
references.citation: Am J Transplant. 2006 Jul;6(7):1586-99
references.pmid: 16827859
references.citation: Nat Rev Drug Discov. 2013 Aug;12(8):595-610
references.pmid: 23807378
references.citation: Liver Transpl. 2013 Jul;19(7):690-700
references.pmid: 23696372
references.citation: Transplantation. 2006 Jul 15;82(1):43-7
references.pmid: 16861940
references.citation: Can J Gastroenterol. 2006 Jul;20(7):479-85
references.pmid: 16858501
references.citation: Ther Clin Risk Manag. 2014 May 24;10:387-94
references.pmid: 24920913
references.citation: Liver Transpl. 2013 Jan;19(1):69-77
references.pmid: 23008144
references.citation: Dig Dis. 2014;32(5):538-44
references.pmid: 25034286
references.citation: Clin Liver Dis. 2005 Aug;9(3):505-23, ix
references.pmid: 16023980
references.citation: Expert Opin Investig Drugs. 2010 Jan;19(1):151-9
references.pmid: 20001560
references.citation: Gastroenterology. 2012 May;142(6):1373-1383.e1
references.pmid: 22537446
references.citation: Science. 1999 Jul 2;285(5424):110-3
references.pmid: 10390360
references.citation: Am J Transplant. 2013 Jun;13(6):1601-5
references.pmid: 23593993
references.citation: Antivir Ther. 2015;20(3):353-6
references.pmid: 25105441
references.citation: Ann Gastroenterol. 2013;26(4):304-313
references.pmid: 24714603
references.citation: Curr Opin Organ Transplant. 2013 Jun;18(3):271-8
references.pmid: 23665543
references.citation: Hepatology. 2005 Feb;41(2):289-98
references.pmid: 15660392
references.citation: J Hepatol. 2014 Jan;60(1):78-86
references.pmid: 23994384
references.citation: Hepat Med. 2014 Apr 29;6:25-33
references.pmid: 24822024
references.citation: J Viral Hepat. 2013 Nov;20(11):745-60
references.pmid: 24168254
references.citation: Dig Liver Dis. 2014 Oct;46(10):923-7
references.pmid: 24997638
references.citation: Expert Rev Gastroenterol Hepatol. 2014 Sep;8(7):725-38
references.pmid: 24882552
references.citation: Semin Liver Dis. 2014 Feb;34(1):108-12
references.pmid: 24782264
references.citation: Antiviral Res. 2014 May;105:64-71
references.pmid: 24583028
references.citation: BMJ. 1991 Sep 28;303(6805):783
references.pmid: 1657257
references.citation: Hepatology. 2011 Jul;54(1):3-5
references.pmid: 21710471
references.citation: Ann Hepatol. 2014 Sep-Oct;13(5):525-32
references.pmid: 25152985
references.citation: Transplantation. 2004 Jan 27;77(2):226-31
references.pmid: 14742986
references.citation: Hepatology. 2002 Mar;35(3):680-7
references.pmid: 11870384
references.citation: Liver Transpl. 2012 Sep;18(9):1053-9
references.pmid: 22706796
references.citation: Exp Clin Transplant. 2014 Apr;12 (2):117-22
references.pmid: 24702143
references.citation: Clin Transplant. 2014 Jul;28(7):821-8
references.pmid: 24806099
references.citation: Ann Intern Med. 2013 Jan 15;158(2):114-23
references.pmid: 23437439
references.citation: Nat Med. 2005 Jul;11(7):791-6
references.pmid: 15951748
references.citation: Gastroenterology. 2015 Jan;148(1):100-107.e1
references.pmid: 25261839
references.citation: Am J Transplant. 2008 Mar;8(3):679-87
references.pmid: 18294165
references.citation: Semin Liver Dis. 2014 Feb;34(1):9-21
references.pmid: 24782254
references.citation: Front Microbiol. 2013 Jul 26;4:213
references.pmid: 23898329